Oxurion NV (LTS:0G99) ROCE %: 0.00% (As of Dec. 2025)


LTS:0G99 Oxurion NV LTS:0G99
9 GF Score
Price €0.27
GF Value €0.91
! 7 Warning Signs
View Full Analysis

What is Oxurion NV ROCE %?

Oxurion NV LTS:0G99 9 ROCE % is 0.00% as of Dec. 2025. GuruFocus rates LTS:0G99 with a GF Score™ of 9/100 and a GF Value™ of €0.91. The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Oxurion NV's annualized ROCE % for the quarter that ended in Dec. 2025 was 0.00%.

Oxurion NV  (LTS:0G99) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Oxurion NV ROCE % Related Terms

Oxurion NV ROCE % Historical Data

* Premium members only.

The historical data trend for Oxurion NV's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxurion NV ROCE % Chart

Oxurion NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -171.13 -832.52 0.00 0.00 0.00

Oxurion NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0G99
9GF Score
Oxurion NV LTS:0G99
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxurion NV ROCE % Calculation

Oxurion NV's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-3.689/( ( (5.695 - 16.623) + (3.825 - 16.178) )/ 2 )
=-3.689/( (-10.928+-12.353)/ 2 )
=-3.689/-11.6405
=31.69 %

Oxurion NV's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-3.79/( ( (4.98 - 16.851) + (3.825 - 16.178) )/ 2 )
=-3.79/( ( -11.871 + -12.353 )/ 2 )
=-3.79/-12.112
=0 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Oxurion NV (LTS:0G99) has a ROCE % of 0.00% as of Dec. 2025.
Is Oxurion NV's ROCE % too high?
Oxurion NV's current ROCE % is 0.00%. Overall, Oxurion NV has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Oxurion NV's ROCE % compare to VRTX and REGN?
Oxurion NV's ROCE % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Oxurion NV's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxurion NV stock overvalued right now?
Oxurion NV (LTS:0G99) has a current ROCE % of 0.00%. The stock's GF Value™ is €0.91, compared to a current price of €0.27 — trading 70% below its estimated fair value. The current ROCE % is 0.00%. Oxurion NV's overall GF Score™ is 9/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Oxurion NV (LTS:0G99), the current ROCE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxurion NV (LTS:0G99) Overvalued in 2026?

Based on GuruFocus' analysis, Oxurion NV stock appears to be undervalued. The current stock price of €0.27 is trading 70% below its estimated GF Value™ of €0.91.

Key valuation signals for LTS:0G99:

  • ROCE %: 0.00%
  • GF Value™: €0.91 vs. price of €0.27 (70% below fair value)
  • GF Score™: 9/100 with 7 warning signs

No single metric tells the full story. See the LTS:0G99 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oxurion NV Business Description

Other Exchanges TG40:GermanyOXUR:Belgium
Address Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a holding company specializing in acquiring and integrating clinical research services companies (CROs) covering the full clinical research value chain across Europe.
9GF Score

Get the complete analysis for LTS:0G99

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.91
GF Value